SCHEMBL26638206

SCHEMBL26638206

C[C@H](Oc1ccc(Br)cc1)C(=O)NOC1CCN(C(=O)O)C1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ MEN1 O00255 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ HPGD P15428 1/20 0.41
▸ APOBEC3A P31941 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ CRHBP P24387 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CRHR2 Q13324 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ DPP4 P27487 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26638209 1.00 ALDH1A1 (0.54) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL22805687 0.93 ALDH1A1 (0.56) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL22805239 0.93 ALDH1A1 (0.56) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL22805539 0.86 ALDH1A1 (0.49) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL22805541 0.86 ALDH1A1 (0.49) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL26638223 0.82 LMNA (0.53) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL26638225 0.82 LMNA (0.53) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL26638193 0.81 LMNA (0.45) ALDH1A1MEN1KMT2ALMNAHPGD
SCHEMBL26638191 0.81 LMNA (0.45) ALDH1A1MEN1KMT2ALMNAHPGD
SCHEMBL26638240 0.79 LMNA (0.46) ALDH1A1MEN1GAAKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986873-B9 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS NMD PHARMA AS (DK) 2024-05-29 — — EP disclosed
EP-3986873-B1 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS NMD PHARMA AS (DK) 2023-11-15 — — EP disclosed
Send feedback